CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net loss	$ (18,904)	$ (30,913)	$ (43,336)
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation	25,524	25,869	24,057
Depreciation and amortization	5,770	4,379	5,428
Accounts receivable credit losses	570	470	761
Inventory reserve	1,997	1,300	1,709
Amortization of discount and premium on marketable securities	(3,051)	(5,440)	(4,009)
Amortization of debt issuance costs	117	153	208
Loss on disposal of property and equipment	1,627	1,877	1,302
Changes in operating assets and liabilities
Accounts receivable	(3,027)	(5,840)	(2,122)
Inventory	(8,684)	(8,047)	(4,719)
Prepaid expenses and other assets	(1,030)	(2)	(762)
Accounts payable	(1,763)	1,861	(1,118)
Accrued liabilities and other	179	1,908	3,888
Net cash used in operating activities	(675)	(12,425)	(18,713)
Cash flows from investing activities
Maturities of marketable securities	205,100	228,500	137,500
Purchases of marketable securities	(192,526)	(205,380)	(189,499)
Purchases of property and equipment	(8,414)	(10,497)	(7,799)
Net cash provided by (used in) investing activities	4,160	12,623	(59,798)
Cash flows from financing activities
Proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs	0	0	83,671
Proceeds from debt financing, net of debt issuance cost	0	35,954	35,960
Repayments of debt financing	0	(36,000)	(35,275)
Final payment fee related to debt	0	(720)	0
Proceeds from the exercise of common stock options	1,169	570	4,386
Proceeds from issuance of common stock under employee stock purchase plan	2,207	2,154	2,191
Net cash provided by financing activities	3,376	1,958	90,933
Effect of exchange rate changes on cash and cash equivalents	431	(479)	132
Net increase in cash and cash equivalents	7,292	1,677	12,554
Cash and cash equivalents at
Beginning of year	34,948	33,271	20,717
End of year	42,240	34,948	33,271
Supplemental disclosure of cash flow information
Cash paid for interest	2,533	3,346	3,263
Noncash investing and financing activities
Operating lease right-of-use assets obtained in exchange for operating lease liabilities	251	449	143
Supplemental disclosure of non-cash information
Unpaid purchases of property and equipment	$ 495	$ 588	$ 501

SI-BONE, Inc. 10-K